Anti-PPP2R5D antibody [EPR15617]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(12 Publications)
Knockout Tested Rabbit Recombinant Monoclonal PPP2R5D antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human, Rat samples. Cited in 12 publications.
View Alternative Names
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform, PP2A B subunit isoform B'-delta, PP2A B subunit isoform B56-delta, PP2A B subunit isoform PR61-delta, PP2A B subunit isoform R5-delta, PPP2R5D
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-PPP2R5D antibody [EPR15617] (AB188323)
ab188323 was shown to react with PPP2R5D in wild-type HAP1 cells in immunocytochemistry with loss of signal observed in a PPP2R5D knockout cell line. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked with 1x PBS, 0.01% Triton X-100, 5% BSA, 5% NGS. The cells were then incubated with ab188323 at dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat anti-rabbit secondary antibody to (Alexa Fluor® 555) at 0.5 ?g/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880).
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PPP2R5D antibody [EPR15617] (AB188323)
Intracellular Flow Cytometry analysis of HeLa cells labeling PPP2R5D using ab188323 at 1/40 dilution (pink). A Goat anti rabbit IgG (FITC) at 1/150 dilution was used as secondary antibody. Cells were fixed with 2% paraformaldehyde. Isotype control : Rabbit monoclonal IgG (green).
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PPP2R5D antibody [EPR15617] (AB188323)
Immunohistochemical analysis of paraffin-embedded Human brain tissue labeling PPP2R5D using ab188323 at 1/100 dilution. A Ready to use HRP Polymer for Rabbit IgG (prediluted) was used as secondary. Counterstain : Hematoxylin.
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PPP2R5D antibody [EPR15617] (AB188323)
Immunofluorescence analysis of HepG2 cells labeling PPP2R5D using ab188323 at 1/250 dilution. A Goat anti rabbit IgG (Alexa Fluor488) at 1/200 dilution was used as secondary antibody. Cells were fixed with 4% Paraformaldehyde. Counterstain : DAPI.
- WB
Lab
Western blot - Anti-PPP2R5D antibody [EPR15617] (AB188323)
ab188323 was shown to react with PPP2R5D in wild-type HAP1 cells in Western blot with loss of signal observed in a PPP2R5D knockout cell line. Wild-type HAP1 and PPP2R5D knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab188323 overnight at 4 °C at a 1/10000 dilution. Blots were incubated with secondary antibodies at 0.2ug/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-PPP2R5D antibody [EPR15617] (ab188323) at 1/10000 dilution
Lane 1:
Wild-type HAP1 lysate at 20 µg
Lane 2:
PPP2R5D knock-out HAP1 lysate at 20 µg
Observed band size: 70 kDa
false
- IP
Supplier Data
Immunoprecipitation - Anti-PPP2R5D antibody [EPR15617] (AB188323)
Immunoprecipitation analysis of 293T cell lysate labeling PPP2R5D using ab188323 at 1/50 dilution. A Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1500 was used as secondary antibody.
All lanes:
Immunoprecipitation - Anti-PPP2R5D antibody [EPR15617] (ab188323)
Predicted band size: 70 kDa
false
- WB
Supplier Data
Western blot - Anti-PPP2R5D antibody [EPR15617] (AB188323)
Based on the sequence analysis, ab188323 recognizes 3 isoforms with the predicted MWs of 58KDa, 66KDa and 70KDa, respectively.
All lanes:
Western blot - Anti-PPP2R5D antibody [EPR15617] (ab188323) at 1/100000 dilution
Lane 1:
C6 cell lysate at 10 µg
Lane 2:
HepG2 cell lysate at 10 µg
Lane 3:
293T cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Lane 5:
Jurkat cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 70 kDa
Observed band size: 70 kDa
false
- WB
Lab
Western blot - Anti-PPP2R5D antibody [EPR15617] (AB188323)
Lanes 1 - 4 : Merged signal (red and green). Green - ab188323 observed at 60-65 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab188323 was shown to react with PPP2R5D in wild-type A431 cells in western blot with loss of signal observed in PPP2R5D knockout sample. Wild-type and PPP2R5D knockout A431 cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab188323 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 10000 Dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PPP2R5D antibody [EPR15617] (ab188323) at 1/10000 dilution
Lane 1:
Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
PPP2R5D knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human PPP2R5D knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-ppp2r5d-knockout-a-431-cell-line-ab270476'>ab270476</a>)
Lane 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 4:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 20 µg
Predicted band size: 70 kDa
Observed band size: 60-65 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PPP2R5D plays an essential role in the regulation of cell growth and division. This protein is part of the PP2A holoenzyme complex which assembles with catalytic and scaffolding subunits. Through its regulatory influence PPP2R5D affects the phosphorylation state of several substrates thereby impacting cellular processes like cell cycle progression and apoptosis.
Pathways
PPP2R5D significantly contributes to the MAPK signaling pathway and the Wnt pathway. It modulates phosphorylation states affecting signal transduction mechanisms. In the MAPK pathway PPP2R5D interacts with proteins like ERK1/2 by influencing their activity. Similarly in the Wnt pathway it acts on components important for maintaining cellular balance and signaling fidelity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
The Journal of biological chemistry 301:110349 PubMed40484382
2025
Applications
Unspecified application
Species
Unspecified reactive species
F1000Research 13:1 PubMed39935523
2025
Applications
WB, ICC, IP
Species
Human, Human, Human
Human molecular genetics 34:193-203 PubMed39565297
2024
Applications
Unspecified application
Species
Unspecified reactive species
Children (Basel, Switzerland) 11: PubMed39201832
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37627221
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:105154 PubMed37572851
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 296:100313 PubMed33482199
2021
Applications
Unspecified application
Species
Unspecified reactive species
eLife 9: PubMed32292164
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 295:5654-5668 PubMed32156701
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed30857592
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com